Eudragit S-100 entrapped chitosan microspheres of valdecoxib for colon cancer.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 20535630)

Published in J Mater Sci Mater Med on June 10, 2010

Authors

Naveen K Thakral1, Alok R Ray, Dipak K Majumdar

Author Affiliations

1: Centre for Biomedical Engineering, Indian Institute of Technology Delhi, Hauz Khas, New Delhi, 110016, India.

Articles cited by this

MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES. J Pharm Sci (1963) 10.98

Aspirin use and reduced risk of fatal colon cancer. N Engl J Med (1991) 7.85

Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv (1985) 6.17

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med (1994) 5.42

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst (2002) 4.97

Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer (2002) 4.02

Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci (1969) 2.74

Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res (1988) 2.28

Pharmaceutical approaches to colon targeted drug delivery systems. J Pharm Pharm Sci (2003) 1.88

Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J Control Release (1998) 1.60

Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention. Lancet Oncol (2002) 1.57

Multiparticulate formulation approach to colon specific drug delivery: current perspectives. J Pharm Pharm Sci (2006) 1.25

Effect of size and density on canine gastric emptying of nondigestible solids. Gastroenterology (1985) 1.17

Extension of the International Conference on Harmonization Tripartite Guideline for Stability Testing of New Drug Substances and Products to countries of climatic zones III and IV. Drug Dev Ind Pharm (1998) 1.14

Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech (2005) 1.12

Why is chitosan mucoadhesive? Biomacromolecules (2008) 1.06

The Melbourne colorectal cancer study: incidence findings by age, sex, site, migrants and religion. Int J Epidemiol (1986) 0.98

Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech (2006) 0.96

Statistical optimisation of diclofenac sustained release pellets coated with polymethacrylic films. Int J Pharm (2003) 0.95

Enteric polymers as binders and coating materials in multiple-unit site-specific drug delivery systems. Eur J Pharm Sci (1999) 0.93

Cardiovascular risks of cyclooxygenase-2 inhibitors: where we stand now. Ann Intern Med (2005) 0.87

Salicylazobenzoic acid in ulcerative colitis. Lancet (1982) 0.86

Insulin loaded eudragit L100 microspheres for oral delivery: preliminary in vitro studies. J Biomater Appl (2006) 0.81

Evaluation of Eudragit-coated chitosan microparticles as an oral immune delivery system. Int J Pharm (2005) 0.81

Sustained increase in the proliferation of rat colonic mucosa during chronic treatment with aspirin. Gastroenterology (1988) 0.77

Articles by these authors

Topical ocular delivery of NSAIDs. AAPS J (2008) 1.25

Three-dimensional chitosan scaffold-based MCF-7 cell culture for the determination of the cytotoxicity of tamoxifen. Biomaterials (2005) 1.17

Development of a new polypropylene-based suture: plasma grafting, surface treatment, characterization, and biocompatibility studies. Macromol Biosci (2010) 1.13

Eudragit S100 entrapped insulin microspheres for oral delivery. AAPS PharmSciTech (2005) 1.12

Preparation and characterization of polyvinyl alcohol-gelatin hydrogel membranes for biomedical applications. AAPS PharmSciTech (2007) 1.02

Effect of formulation factors on in vitro transcorneal permeation of gatifloxacin from aqueous drops. AAPS PharmSciTech (2006) 1.01

Biological activities of Ocimum sanctum L. fixed oil--an overview. Indian J Exp Biol (2007) 0.98

Therapeutic effect of Linum usitatissimum (flaxseed/linseed) fixed oil on acute and chronic arthritic models in albino rats. Inflammopharmacology (2010) 0.96

The quest for targeted delivery in colon cancer: mucoadhesive valdecoxib microspheres. Int J Nanomedicine (2011) 0.96

Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas. AAPS PharmSciTech (2006) 0.95

Evaluation of antiulcer and antisecretory potential of Linum usitatissimum fixed oil and possible mechanism of action. Inflammopharmacology (2010) 0.92

Polyvinyl alcohol-glycine composite membranes: preparation, characterization, drug release and cytocompatibility studies. Biomed Mater (2006) 0.87

Anti-inflammatory, analgesic and antipyretic activities of Linum usitatissimum L. (flaxseed/linseed) fixed oil. Indian J Exp Biol (2011) 0.87

Preparation of scaffolds from human hair proteins for tissue-engineering applications. Biomed Mater (2008) 0.87

Release behaviour of drugs from tamarind seed polysaccharide tablets. J Pharm Pharm Sci (2002) 0.86

Eudragit: a technology evaluation. Expert Opin Drug Deliv (2012) 0.86

Combined miRNA and mRNA signature identifies key molecular players and pathways involved in chikungunya virus infection in human cells. PLoS One (2013) 0.84

In vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note. AAPS PharmSciTech (2005) 0.84

Synthesis of blood compatible polyamide block copolymers. Biomaterials (2002) 0.84

Formation and characterization of three dimensional human hepatocyte cell line spheroids on chitosan matrix for in vitro tissue engineering applications. In Vitro Cell Dev Biol Anim (2007) 0.82

Development of enteric submicron particle formulation of papain for oral delivery. Int J Nanomedicine (2011) 0.82

Strategies for replicating anatomical cartilaginous tissue gradient in engineered intervertebral disc. ACS Appl Mater Interfaces (2013) 0.81

The role of 3D structure and protein conformation on the innate and adaptive immune responses to silk-based biomaterials. Biomaterials (2013) 0.81

Enteric microsphere formulations of papain for oral delivery. Yakugaku Zasshi (2011) 0.81

Formulation, characterization and evaluation of rotavirus encapsulated PLA and PLGA particles for oral vaccination. J Microencapsul (2009) 0.80

Linum usitatissimum (linseed/flaxseed) fixed oil: antimicrobial activity and efficacy in bovine mastitis. Inflammopharmacology (2010) 0.80

Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery. Colloids Surf B Biointerfaces (2012) 0.80

Acrylic acid-methyl methacrylate copolymer for oral prolonged drug release. J Mater Sci Mater Med (2010) 0.79

Fabrication of agar-gelatin hybrid scaffolds using a novel entrapment method for in vitro tissue engineering applications. Biotechnol Bioeng (2007) 0.79

Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery. J Microencapsul (2011) 0.79

Design and evaluation of moxifloxacin hydrochloride ocular inserts. Acta Pharm (2012) 0.79

Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note. AAPS PharmSciTech (2006) 0.79

Soluplus--solubilized citrated camptothecin--a potential drug delivery strategy in colon cancer. AAPS PharmSciTech (2011) 0.78

Oriented lamellar silk fibrous scaffolds to drive cartilage matrix orientation: towards annulus fibrosus tissue engineering. Acta Biomater (2012) 0.78

Enhanced redifferentiation of chondrocytes on microperiodic silk/gelatin scaffolds: toward tailor-made tissue engineering. Biomacromolecules (2013) 0.78

Abattoir-sourced isolated ileum from Gallus gallus domesticus as an experimental tool. Altern Lab Anim (2010) 0.78

Culture & differentiation of mesenchymal stem cell into osteoblast on degradable biomedical composite scaffold: In vitro study. Indian J Med Res (2015) 0.77

Effect of L. usitatissimum (Flaxseed/Linseed) Fixed Oil against Distinct Phases of Inflammation. ISRN Inflamm (2013) 0.77

Agar-gelatin hybrid sponge-induced three-dimensional in vitro 'liver-like' HepG2 spheroids for the evaluation of drug cytotoxicity. J Tissue Eng Regen Med (2009) 0.77

Improved immunogenicity of biodegradable polymer particles entrapped rotavirus vaccine. J Biomater Appl (2010) 0.77

Topical ocular delivery of fluoroquinolones. Expert Opin Drug Deliv (2013) 0.77

Development of enteric submicron particles formulation of α-amylase for oral delivery. Pharm Dev Technol (2011) 0.76

Development and characterization of itraconazole-loaded solid lipid nanoparticles for ocular delivery. Pharm Dev Technol (2014) 0.76

Acrylic acid-methyl methacrylate (2.5:7.5/2:8) enteric copolymer for colon targeted drug delivery. J Mater Sci Mater Med (2010) 0.75

Hydrogels for biomedical applications: a short review. J Mater Sci Mater Med (2007) 0.75

Extraction of metal ions using chemically modified silica gel covalently bonded with 4,4'-diaminodiphenylether and 4,4'-diaminodiphenylsulfone-salicylaldehyde Schiff bases. Anal Sci (2006) 0.75

Synthesis, characterization, and blood compatibility of polyamidoamines copolymers. Biomaterials (2003) 0.75

Is relief from diabetes just a breath away? Curr Drug Deliv (2009) 0.75